Scynexis (SCYX) Retained Earnings (2013 - 2026)
Scynexis' (SCYX) quarterly Retained Earnings came in at -$406.4 million in Q1 2026, down 193.98% YoY from $432.4 million in Q1 2025, and down 193.54% on a QoQ basis from $434.5 million in Q4 2025.
Scynexis (SCYX) Retained Earnings (2013 - 2026) Analysis & Trends
Scynexis (SCYX) has 14 years of Retained Earnings data on file, last reported at -$406.4 million in Q1 2026.
- Quarterly Retained Earnings fell 193.98% year-over-year to -$406.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$406.4 million (down 193.98% YoY) and the FY2025 annual result came in at $434.5 million, up 0.67% from the prior year.
- Retained Earnings slipped to -$406.4 million in Q1 2026, from $434.5 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $434.5 million in Q4 2025 to a low of -$456.2 million in Q1 2023.
- A 5-year average of -$100.1 million and a median of -$364.9 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2024 — Retained Earnings soared 221.48% — and 2026, when it plunged 193.98%.
- Tracing SCYX's Retained Earnings over 5 years: stood at -$422.3 million in 2022, then climbed by 15.88% to -$355.2 million in 2023, then soared by 221.48% to $431.6 million in 2024, then gained by 0.67% to $434.5 million in 2025, then sank by 193.54% to -$406.4 million in 2026.
- The last three Retained Earnings figures came in at -$406.4 million (Q1 2026), $434.5 million (Q4 2025), and -$397.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | Scynexis | 61.37 Mn | -53.33 Mn | - | 465.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 465.97 Mn |
| Mar 31, 2026 | -406.40 Mn |
| Dec 31, 2025 | 434.47 Mn |
| Sep 30, 2025 | -397.40 Mn |
| Jun 30, 2025 | -388.81 Mn |
| Mar 31, 2025 | 432.42 Mn |
| Dec 31, 2024 | 431.57 Mn |
| Sep 30, 2024 | -372.10 Mn |
| Jun 30, 2024 | 429.66 Mn |
| Mar 31, 2024 | 428.90 Mn |
| Dec 31, 2023 | -355.25 Mn |
| Sep 30, 2023 | -335.70 Mn |
| Jun 30, 2023 | 426.94 Mn |
| Mar 31, 2023 | -456.16 Mn |
| Dec 31, 2022 | -422.29 Mn |
| Sep 30, 2022 | -407.90 Mn |
| Jun 30, 2022 | -378.28 Mn |
| Mar 31, 2022 | -364.93 Mn |
| Dec 31, 2021 | -359.48 Mn |
| Sep 30, 2021 | -330.20 Mn |